These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9637577)

  • 61. Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.
    Jackson JB; Hom D; Piwowar E; Ndugwa C; Kataaha P; Marum L; Guay L; Parsons J; Olness K; Mmiro F
    Pediatr AIDS HIV Infect; 1996 Feb; 7(1):37-42. PubMed ID: 11361471
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G; Mary JY; Coeur SL; Ngo-Giang-Huong N; Yuthavisuthi P; Limtrakul A; Traisathit P; McIntosh K; Lallemant M;
    J Infect Dis; 2007 Dec; 196(11):1629-36. PubMed ID: 18008246
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections.
    John GC; Nduati RW; Mbori-Ngacha DA; Richardson BA; Panteleeff D; Mwatha A; Overbaugh J; Bwayo J; Ndinya-Achola JO; Kreiss JK
    J Infect Dis; 2001 Jan; 183(2):206-212. PubMed ID: 11120927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence and predictive value of intermittent viremia with combination hiv therapy.
    Havlir DV; Bassett R; Levitan D; Gilbert P; Tebas P; Collier AC; Hirsch MS; Ignacio C; Condra J; Günthard HF; Richman DD; Wong JK
    JAMA; 2001 Jul; 286(2):171-9. PubMed ID: 11448280
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy.
    Debiaggi M; Zara F; Spinillo A; De Santolo A; Maserati R; Bruno R; Sacchi P; Achilli G; Pistorio A; Romero E; Filice G
    Eur J Clin Microbiol Infect Dis; 2001 Feb; 20(2):91-6. PubMed ID: 11305478
    [TBL] [Abstract][Full Text] [Related]  

  • 69. After AIDS clinical trial 076: the changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group.
    Cooper ER; Nugent RP; Diaz C; Pitt J; Hanson C; Kalish LA; Mendez H; Zorrilla C; Hershow R; Moye J; Smeriglio V; Fowler MG
    J Infect Dis; 1996 Dec; 174(6):1207-11. PubMed ID: 8940210
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission.
    Larbalestier N; Mullen J; O'Shea S; Cottam F; Sabin CA; Chrystie IL; Welch J; Zuckerman M; Hay P; Rice P; Taylor GP; de Ruiter A
    AIDS; 2003 Dec; 17(18):2665-7. PubMed ID: 14685064
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].
    Palacios R; Senise JF; Vaz MJ; Castelo A
    Enferm Infecc Microbiol Clin; 2008; 26(7):411-5. PubMed ID: 18842235
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial.
    Taha TE; Kumwenda NI; Gibbons A; Broadhead RL; Fiscus S; Lema V; Liomba G; Nkhoma C; Miotti PG; Hoover DR
    Lancet; 2003 Oct; 362(9391):1171-7. PubMed ID: 14568737
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prevention of perinatal HIV transmission during pregnancy.
    McGowan JP; Shah SS
    J Antimicrob Chemother; 2000 Nov; 46(5):657-68. PubMed ID: 11062184
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy.
    Clarke JR; Braganza R; Mirza A; Stainsby C; Ait-Khaled M; Wright A; Lyall H; Parker D; McClure MO; Weber JN; Taylor GP
    J Med Virol; 1999 Nov; 59(3):364-8. PubMed ID: 10502270
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?
    Galli L; Puliti D; Chiappini E; Gabiano C; Ferraris G; Mignone F; Viganò A; Giaquinto C; Genovese O; Anzidei G; Badolato R; Buffolano W; Maccabruni A; Salvini F; Cellini M; Ruggeri M; Manzionna M; Bernardi S; Tovo P; de Martino M;
    Clin Infect Dis; 2009 May; 48(9):1310-7. PubMed ID: 19309307
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children.
    Abrams EJ; Wiener J; Carter R; Kuhn L; Palumbo P; Nesheim S; Lee F; Vink P; Bulterys M;
    AIDS; 2003 Apr; 17(6):867-77. PubMed ID: 12660534
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection.
    Supapol WB; Remis RS; Raboud J; Millson M; Tappero J; Kaul R; Kulkarni P; McConnell MS; Mock PA; Culnane M; McNicholl J; Roongpisuthipong A; Chotpitayasunondh T; Shaffer N; Butera S
    J Infect Dis; 2008 May; 197(10):1369-77. PubMed ID: 18419578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.